Skip to main content

Table 4 Stage distributions of EC under the screening and nonscreening scenarios

From: Modeling the Cost-effectiveness of Esophageal Cancer Screening in China

Stage Nonscreening (%) Screening (%) Distribution
Proportion SA range Proportion SA range
IC 3.65 2.92–4.38 88.24 70.59–100.00 Dirichlet
SM 4.93 3.94–5.92 2.52 2.02–3.02
Mod 66.06 52.85–79.27 6.72 5.38–8.06
Adv 25.36 20.29–30.43 2.52 2.02–3.02
  1. SA one-way sensitivity analysis
\